Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Brain, Behavior, and Immunity|August 15, 2024
LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease modelsSusan Acton, Michelle M O'Donnell, Kalaichitra Periyasamy, et al.Frontiers in Microbiology|January 25, 2024
ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier functionSophie Irwin, Andrea Chupina Estrada, Becca Nelson, et al.Journal of Global Antimicrobial Resistance|July 11, 2017
In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agentsCédric Jacqueline, Karen Howland, Laurent ChesnelThe Journal of Biological Chemistry|November 24, 2005
Pneumococcal beta-lactam resistance due to a conformational change in penicillin-binding protein 2xRaphaël Carapito, Laurent Chesnel, Thierry Vernet, et al.Molecular Microbiology|April 28, 2005
A yeast genetic system for the identification and characterization of substrate proteins transferred into host cells by the Legionella pneumophila Dot/Icm systemEva M Campodonico, Laurent Chesnel, Craig R RoyJournal of Industrial Microbiology & Biotechnology|December 17, 2015
Discovery and development of surotomycin for the treatment of Clostridium difficileVictoria Knight-Connoni, Carmela Mascio, Laurent Chesnel, et al.European Journal of Biochemistry|March 16, 2002
Increase of the deacylation rate of PBP2x from Streptococcus pneumoniae by single point mutations mimicking the class A beta-lactamasesLaurent Chesnel, André Zapun, Nicolas Mouz, et al.Antimicrobial Agents and Chemotherapy|May 7, 2014
Surotomycin demonstrates low in vitro frequency of resistance and rapid bactericidal activity in Clostridium difficile, Enterococcus faecalis, and Enterococcus faeciumCarmela T M Mascio, Laurent Chesnel, Grace Thorne, et al.Antimicrobial Agents and Chemotherapy|May 6, 2015
Mutations associated with reduced surotomycin susceptibility in Clostridium difficile and Enterococcus speciesHannah M Adams, Xiang Li, Carmela Mascio, et al.Journal of Clinical Microbiology|December 18, 2015
Impact of Variations in Test Method Parameters on In Vitro Activity of Surotomycin against Clostridium difficile and Surotomycin Quality Control Limits for Broth Microdilution and Agar Dilution Susceptibility TestingMaria M Traczewski, Jennifer Deane, Daniel Sahm, et al.Pageof 4